NDAINJECTIONINJECTABLEPriority Review
Approved
Dec 1981
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 13h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PIPRACIL (piperacillin sodium) is a broad-spectrum beta-lactam antibiotic administered via injection for treatment of serious bacterial infections. It works by inhibiting bacterial cell wall synthesis, making it effective against gram-positive and gram-negative organisms. This is a mature, off-patent antibiotic used across hospital and acute care settings.
LOE Approaching
As an approaching LOE product with moderate competitive pressure (30%), this asset faces revenue erosion and likely has a right-sizing commercial team focused on retention and efficiency.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on PIPRACIL offers limited career growth as a mature, generic-competitive antibiotic in LOE. Career value lies in operational excellence, hospital relationship management, and supply chain optimization rather than innovation or market expansion.
Account Manager (Hospital/IDN)Supply Chain Manager
Worked on PIPRACIL at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.